These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 6895577)
1. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study. High WB; Capen CC; Black HE Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577 [TBL] [Abstract][Full Text] [Related]
2. Histomorphometric evaluation of the effects of intermittent 1,25-dihydroxycholecalciferol administration on cortical bone remodeling in adult dogs. High WB; Capen CC; Black HE Am J Pathol; 1981 Jul; 104(1):41-9. PubMed ID: 6894823 [TBL] [Abstract][Full Text] [Related]
3. Effects of thyroxine on cortical bone remodeling in adult dogs: a histomorphometric study. High WB; Capen CC; Black HE Am J Pathol; 1981 Mar; 102(3):438-46. PubMed ID: 7212021 [TBL] [Abstract][Full Text] [Related]
4. Histomorphometric evaluation of the effects of low dose parathyroid hormone administration on cortical bone remodeling in adult dogs. High WB; Black HE; Capen CC Lab Invest; 1981 May; 44(5):449-54. PubMed ID: 7230731 [TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse. Marie PJ; Travers R Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545 [TBL] [Abstract][Full Text] [Related]
6. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis? Joffe P; Heaf JG; Jensen C Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626 [TBL] [Abstract][Full Text] [Related]
7. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. Christiansen P APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022 [TBL] [Abstract][Full Text] [Related]
8. [Bone changes with long term administration of low dose 1-34 human PTH on adult beagles]. Inoue J Nihon Seikeigeka Gakkai Zasshi; 1985 Apr; 59(4):409-27. PubMed ID: 4031575 [TBL] [Abstract][Full Text] [Related]
9. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794 [TBL] [Abstract][Full Text] [Related]
10. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations. Rosol TJ; Capen CC; Horst RL J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193 [TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Malluche HH; Matthews C; Faugere MC; Fanti P; Endres DB; Friedler RM Endocrinology; 1986 Sep; 119(3):1298-304. PubMed ID: 3755395 [TBL] [Abstract][Full Text] [Related]
12. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Malluche HH; Faugere MC; Friedler RM; Fanti P Endocrinology; 1988 May; 122(5):1998-2006. PubMed ID: 3359973 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term infusion of physiologic doses of 1-34 PTH on bone. Malluche HH; Sherman D; Meyer W; Ritz E; Norman AW; Massry SG Am J Physiol; 1982 Feb; 242(2):F197-201. PubMed ID: 7065136 [TBL] [Abstract][Full Text] [Related]
15. Changes in histomorphometric values of iliac trabecular bone and serum biochemical constituents related to bone metabolism in beagle dogs during growth. Fukuda S; Iida H Jikken Dobutsu; 1994 Apr; 43(2):159-65. PubMed ID: 8174616 [TBL] [Abstract][Full Text] [Related]
16. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947 [TBL] [Abstract][Full Text] [Related]
17. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3. Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902 [TBL] [Abstract][Full Text] [Related]
18. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet. Goulding A; Gold E; Fisher L Bone Miner; 1990 Mar; 8(3):185-93. PubMed ID: 2322693 [TBL] [Abstract][Full Text] [Related]
19. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131 [TBL] [Abstract][Full Text] [Related]
20. [Effect of human PTH on steroid-induced osteopenia: a histomorphometric study of decalcified and undecalcified trabecular bone sections in rat]. Unoki E Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1064-75. PubMed ID: 8551091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]